SYAXF
Elevra Lithium Ltd
$7.31
-4.57%
No data for this timeframe.
Vol
SEC Reports3
Exchange OTC·Sector Mining & Quarrying of Nonmetallic Minerals (No Fuels)·Inc. C3·CIK 0001739016·Prev Close $7.66
Recent Activity
May 14, 2026
SEC
Elevra Lithium completed a fully underwritten A$275 million institutional placement, issuing ~22.5 million new shares at
6-K — Impact 6/10
May 13, 2026
SEC
Elevra Lithium released an updated scoping study for the staged expansion of its North American Lithium (NAL) mine, show
6-K — Impact 7/10
May 11, 2026
SEC
Elevra Lithium has agreed to sell its interest in the Ewoyaa Lithium Project in Ghana to Zhejiang Huayou Cobalt for appr
6-K — Impact 7/10
Analyst Ratings
1Strong Buy
4Buy
2Hold
0Sell
0Strong Sell
Latest Reports
BEARISH
6-K
6/10
Elevra Lithium completed a fully underwritten A$275 million institutional placement, issuing ~22.5 million new shares at
May 14, 2026
BULLISH
6-K
7/10
Elevra Lithium released an updated scoping study for the staged expansion of its North American Lithium (NAL) mine, show
May 13, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 2 bullish, 1 bearish, 0 mixed, 0 neutral. Avg impact: 6.7/10.
BEARISH
6-K
6/10
Elevra Lithium completed a fully underwritten A$275 million institutional placement, issuing ~22.5 m
May 14, 2026
BULLISH
6-K
7/10
Elevra Lithium released an updated scoping study for the staged expansion of its North American Lith
May 13, 2026
BULLISH
6-K
7/10
Elevra Lithium has agreed to sell its interest in the Ewoyaa Lithium Project in Ghana to Zhejiang Hu
May 11, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 71% buy across 7 analysts — 1 strong buy, 4 buy, 2 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.4B | 58.1% | — |
| Next FY 2027-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.5B | 47.8% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 1 | 4 | 2 | 0 | 0 | 71% | |
| May 1, 2026 | 1 | 5 | 1 | 0 | 0 | 86% | |
| Apr 1, 2026 | 1 | 5 | 1 | 0 | 0 | 86% | |
| Mar 1, 2026 | 1 | 5 | 1 | 0 | 0 | 86% | |
| Feb 1, 2026 | 1 | 4 | 2 | 0 | 0 | 71% | |
| Jan 1, 2026 | 1 | 4 | 1 | 0 | 0 | 83% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.